Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

by Andrew M. Blumenfeld, Richard J. Stark, Marshall C. Freeman, Amelia Orejudos, Aubrey Manack Adams
Published 2018-02-01

The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis

by Manjit Matharu, Rashmi Halker, Patricia Pozo-Rosich, Ronald DeGryse, Aubrey Manack Adams, Sheena K. Aurora
Published 2017-08-01

Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

by Andrew M. Blumenfeld, Atul T. Patel, Ira M. Turner, Kathleen B. Mullin, Aubrey Manack Adams, John F. Rothrock
Published 2020-09-01

Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics

by Gerard E. Francisco, Daniel S. Bandari, Ganesh Bavikatte, Wolfgang H. Jost, Aubrey Manack Adams, Joan Largent, Alberto Esquenazi
Published 2017-06-01

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis

by Hans-Christoph Diener, David W. Dodick, Richard B. Lipton, Aubrey Manack Adams, Ronald E. DeGryse, Stephen D. Silberstein
Published 2020-10-01

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine

by Stephen D. Silberstein, Hans-Christoph Diener, David W. Dodick, Aubrey Manack Adams, Ronald E. DeGryse, Richard B. Lipton
Published 2020-10-01

Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study

by William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Published 2019-02-01

Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study

by William B. Young, J. Ivan Lopez, John F. Rothrock, Amelia Orejudos, Aubrey Manack Adams, Richard B. Lipton, Andrew M. Blumenfeld
Published 2019-01-01

Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design

by Daniel Serrano, Richard B. Lipton, Ann I. Scher, Michael L. Reed, Walter (Buzz) F. Stewart, Aubrey Manack Adams, Dawn C. Buse
Published 2017-10-01